Wedbush Initiates Coverage of Janux Therapeutics (JANX) with Outperform Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on April 6, 2023,
Wedbush
initiated coverage of Janux Therapeutics (NASDAQ:JANX) with
a Outperform recommendation.
Wedbush
initiated coverage of Janux Therapeutics (NASDAQ:JANX) with
a Outperform recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1346781100-2724c28da6b2479b88db9d1337ebe926.jpg "Buy Now, Pay Later or Rent-to-Own: Which Is the Smarter Way to Pay for Purchases?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1917868586-d64880817bca4098bc8be36bbd17a4e9.jpg "Should You Trade Options on Spot Bitcoin ETFs?")